• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Investing

Nvidia teams up with Abridge to build AI model for healthcare: report

by June 11, 2026
written by June 11, 2026

Nvidia is expanding its presence in healthcare artificial intelligence through a new partnership with medical technology startup Abridge, as competition intensifies among technology companies seeking to apply AI tools across the healthcare industry.

According to a report by The Wall Street Journal, Nvidia and Abridge are developing an AI model specifically designed for clinical conversations between doctors and patients.

The model will be deployed exclusively within Abridge’s platform and is intended to improve medical documentation, clinical decision support, and other healthcare workflows.

Nvidia is already an investor in the Pittsburgh-based startup, which has emerged as one of the leading providers of AI-powered note-taking tools for healthcare professionals.

Focus on clinical intelligence

The new model will be built using Nvidia’s Nemotron family of open AI models and then customized using Abridge’s healthcare expertise and clinical data.

Kimberly Powell, Nvidia’s vice president of healthcare, said the partnership reflects a broader effort to adapt AI models for specialized industries.

“There’s an opportunity now to take these models and adapt them with this clinical intelligence at a much earlier stage of model development,” Powell said.

Unlike general-purpose AI models, the healthcare-focused system is being trained to understand the nuances of doctor-patient interactions, medical terminology and clinical decision-making.

Powell said the collaboration also demonstrates how Nvidia’s open models can be tailored for sectors such as drug discovery, medical devices, and digital health.

“Nvidia has been known to be the AI company that works with every other AI company,” Powell added.

Healthcare becomes the next AI battleground

The announcement comes amid a broader race among technology firms to build healthcare-focused AI products.

Last week, Microsoft unveiled a collaboration with Mayo Clinic aimed at creating a healthcare-specific AI model trained on clinical data.

OpenAI and Anthropic have also introduced healthcare offerings targeted at both consumers and medical professionals.

The growing interest reflects the size of the healthcare market and the potential for AI to reduce administrative burdens, improve productivity, and assist with clinical decision-making.

For Abridge, the partnership offers access to Nvidia’s AI infrastructure while allowing the company to incorporate years of clinical expertise into the model.

Abridge brings medical data and expertise

Abridge plans to use de-identified clinical data gathered through its platform to further train and customize the model.

“Generic models are powerful, but clinical intelligence it still has to be trained, it has to be shaped, and it has to be evaluated against real-world conditions. That’s a lot of our early experiments and work with the Nemotron team,” said Dr. Shiv Rao, Abridge’s co-founder and chief executive.

Founded in 2018, Abridge specializes in ambient-listening technology that records conversations between doctors and patients and automatically generates clinical notes.

The company raised $300 million last year in a funding round that valued it at $5.3 billion, underscoring investor enthusiasm for healthcare AI applications.

The new model is expected to become one of several AI systems powering Abridge’s platform when it launches later this year.

According to Davis Liang, Abridge’s director of applied science, the company previously developed its own speech-recognition model because existing third-party systems were not optimized for hospital environments and medical terminology.

Cost efficiency is another factor driving the partnership.

Liang said smaller, purpose-built open models are often less expensive than proprietary alternatives and can be deployed on Abridge’s own infrastructure.

Hospitals see potential beyond documentation

Healthcare providers are already exploring how the technology could evolve beyond note-taking.

Dr. Joon Lee, chief executive of Emory Healthcare, said the health system has rolled out Abridge’s platform to more than 3,000 physicians.

Lee believes increasingly sophisticated AI tools could eventually provide real-time support during patient consultations.

“The doctor-patient conversation is at the center of so much decision-making and information exchange,” Lee said.

“I’m excited about the possibility of intelligence coming more and more in real-time.”

As healthcare becomes one of the most competitive frontiers for artificial intelligence, Nvidia’s latest partnership signals that the battle for medical AI leadership is only beginning.

The post Nvidia teams up with Abridge to build AI model for healthcare: report appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Nvidia teams up with Abridge to build AI model for healthcare: report
next post
Column: Wall Street’s AI-fueled surge is running into resistance

related articles

Michael Burry takes profits on Nvidia puts as...

November 20, 2026

Why Intel shares are falling over 5% on...

November 20, 2026

PayPal stock falls 4% as leadership shake-up tests...

November 20, 2026

Evening digest: Anthropic slides after record debut, Bitcoin...

November 20, 2026

Why Broadcom shares are down over 11% on...

November 20, 2026

Why CoreWeave and Nebius stocks are falling on...

November 20, 2026

SpaceX stock slips: why its 8.26% bond yield...

November 20, 2026

These 3 stocks are must-own for investors who...

November 20, 2026

Why is Tesla stock falling over 3% today?

November 20, 2026

Why AMD shares are tumbling over 6% on...

November 20, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • WATCH: AOC leaves door open to 2028 White House bid: ‘Maybe, maybe not’

    June 5, 2026
  • Applied Materials, KLA stocks gain as AI boom lifts chip equipment outlook

    June 11, 2026
  • Did Trump discuss Jensen Huang controversy with Xi? Here’s what he said

    November 19, 2026
  • AMD stock gains 3%, here’s why

    October 2, 2026
  • Microsoft stock rises as Melius upgrades to Buy, sees over 26% upside

    October 5, 2026

Popular Posts

  • 1

    Why SpaceX stock is down around 3% on Tuesday

    September 15, 2026
  • 2

    Micron stock falls 4%, why this analyst sees 40% upside for the stock?

    September 28, 2026
  • 3

    Evening digest: US jobs cool, gold falls as Treasury yields rise

    October 2, 2026
  • 4

    Nike stock sinks after earnings as its comeback plan turns into more layoffs

    October 2, 2026
  • 5

    Dow rises 260 points as weak jobs data lifts US stocks

    October 2, 2026

Categories

  • Editor's Pick (711)
  • Investing (2,690)
  • Stock (90)

Latest Posts

  • Blue state mayor arrested for fraud sparks uproar for not speaking English in viral clip: ‘How is this real’

    August 18, 2026
  • Why is Oracle stock slumping 5% today

    September 24, 2026
  • China’s technology IPO market rebounds on AI and semiconductor push

    June 26, 2026

Recent Posts

  • Dell stock soars on blowout earnings, outlook: why analysts see a major rerating

    September 2, 2026
  • Mail-voting crackdown moves ahead as Trump court win opens door to federal action

    August 28, 2026
  • SpaceX stock continues to dip ahead of Russell 1000 inclusion

    June 25, 2026

Editor’s Pick

  • Why Nvidia shares are rising on Monday?

    October 26, 2026
  • Anthropic set to price its IPO tonight, with reports pointing above $80

    November 18, 2026
  • Wall Street just upgraded these 3 AI stocks to ‘Buy’: here’s why

    October 13, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock